The document describes the design of a pharmaceutical plant to produce the HIV/AIDS drug Stavudine. Key aspects of the design include a three-reactor production process, recycling of solvents to reduce costs and waste, and safety features to protect workers from hazardous chemicals. Economic analysis shows the plant would be profitable, with an internal rate of return of 49.3% and potential to increase annual profits.